From: Fauci, Anthony (NIH/NIAID) [E]

Sent: Thu, 13 Feb 2020 22:44:12 +0000
To: Stoffels, Paul [JICUS]
Ce: Riccobene, Kim (JJCUS];Van Hoof, Johan [JRDBE];Conrad, Patricia (NIH/NIAID)

[E];Barasch, Kimberly (NIH/NIAID) [C];Eisinger, Robert (NIH/NIAID) [E];Marston, Hilary (NIH/NIAID)
[E];Lerner, Andrea (NIH/NIAID) [E];Mascola, John (NIH/VRC) [E];Erbelding, Emily (NIH/NIAID) [E]
Subject: RE: COVID-19 vaccine development

Paul:
Thanks for the note. | will have Patty Conrad (copied here) try to work

something out for Feb. 215" My schedule is at the mercy of the White House and
the Congress and so | cannot guarantee anything right now.
Best Regards,

Tony

Anthony S. Fauci, MD

Director

National Institute of Allergy and Infectious Diseases
Building 31, Room 7A-03

31 Center Drive, MSC 2520

National Institutes of Health

Bethesda, MD 20892-2520

Phone:

FAX: (301 496-4409
E-mailz
The information in this e-mail and any of its attachments is confidential and may contain sensitive
information. It should not be used by anyone who is not the original intended recipient. If you
have received this e-mail in error please inform the sender and delete it from your mailbox or any
other storage devices. The National Institute of Allergy and Infectious Diseases (NIAID) shall not
accept liability for any statements made that are the sender's own and not expressly made on
behalf of the NIAID by one of its representatives.

  

From: Stoffels, Paul (UCUS|[ OY >

Sent: Thursday, February 13, 2020 9:42 AM
To: Fauci, Anthony (NIH/NIAID) [E] <

Cc: Riccobene, Kim [JJCUS] CY); Ss ven toot Johan JROBE) EO G]>

Subject: COVID-19 vaccine development

 

Dear Tony,

Four weeks ago our team kicked of the experimental work on the development of a COVID-19 - vaccine.

NIH-001918
